Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Change in Inventory: 2011-2025

Historic Change in Inventory for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $4.4 million.

  • Niagen Bioscience's Change in Inventory rose 553.46% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 496.49%. This contributed to the annual value of -$5.3 million for FY2024, which is 3408.55% down from last year.
  • According to the latest figures from Q3 2025, Niagen Bioscience's Change in Inventory is $4.4 million, which was up 36.14% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Change in Inventory ranged from a high of $4.4 million in Q3 2025 and a low of -$2.8 million during Q1 2023.
  • Its 3-year average for Change in Inventory is $374,000, with a median of $65,000 in 2023.
  • In the last 5 years, Niagen Bioscience's Change in Inventory surged by 656.41% in 2023 and then slumped by 1,613.85% in 2024.
  • Niagen Bioscience's Change in Inventory (Quarterly) stood at $926,000 in 2021, then crashed by 203.56% to -$959,000 in 2022, then skyrocketed by 298.23% to $1.9 million in 2023, then slumped by 171.12% to -$1.4 million in 2024, then soared by 553.46% to $4.4 million in 2025.
  • Its Change in Inventory was $4.4 million in Q3 2025, compared to $3.2 million in Q2 2025 and $2.0 million in Q1 2025.